Stock vs Stock Comparison

Edwards Lifesciences Corporation vs Agilent Technologies, Inc.

EW and A are evenly matched across key metrics.

EW$86.00
A$137.40

🏆 Tale of the Tape

44
EWA
17.7%Profitability (Net Margin)18.8%
46.7xValuation (P/E)27.3x
8.6%Efficiency (ROIC)11.8%
5/9Health (Piotroski F)5/9
10.7Safety (Altman Z)4.6
11.6%Growth (Rev YoY)6.7%
0.38Risk (Sharpe 1Y)0.32
0.33xBalance Sheet (D/E)0.89x
3.11%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.238
252-Day Correlation
0.267
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricEWA
Market Cap$49.8B$38.2B
P/E Ratio46.7x27.3x
Forward P/E25.7x20.5x
P/B4.83x5.37x
Dividend Yield0.75%
Beta0.871.22

Quantitative Metrics

MetricEWA
DCF Fair Value$69.22$50.34
DCF Upside-11.4%-57.1%
Piotroski F5/95/9
Altman Z10.724.57
Beneish M-2.47-2.46
FCF Yield3.11%3.41%
Net Debt/EBITDA-1.6x0.7x
ROIC8.6%11.8%
WACC10.6%12.1%
ROIC – WACC-2.0pp-0.3pp
Gross Margin78.0%52.4%
Net Margin17.7%18.8%
Rev Growth YoY11.6%6.7%
Sharpe (1Y)0.380.32
Max Drawdown 3Y
FCF Payout Ratio24%

EW Price

Loading chart...

A Price

Loading chart...

ETF Exposure

EW found in:

IHI4.98%
XHE1.67%
VOT1.14%
XLV0.90%
VHT0.78%
VO0.49%
ONEO0.19%
VTV0.19%
RSP0.19%
SCHV0.17%
IWD0.15%
VONV0.15%
QUS0.11%
SPYV0.09%
ESGV0.09%
IVV0.08%
SPLG0.08%
SCHX0.08%
VOO0.08%
SPY0.08%
SCHB0.08%
ITOT0.07%
VTI0.07%
VONE0.07%
SPTM0.07%
SPYG0.06%
URTH0.06%
ACWI0.05%
VT0.04%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

EW vs A: Head-to-Head Analysis

Edwards Lifesciences Corporation (EW) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, EW generates a return on invested capital (ROIC) of 8.6% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between EW and A is 0.238, indicating low correlation, making them an effective diversification pair in a portfolio context.

EW appears in 29 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, EW or A?

Our quantitative analysis compares EW and A across nine fundamental dimensions. EW and A are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are EW and A correlated?

The 252-day correlation between EW and A is 0.238. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.